SYROS PHARMACEUTICALS, INC. Current Liabilities
SYROS PHARMACEUTICALS, INC. had Current Liabilities of $28.39 million as of 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2024-10-31
- 2024-09-30: Liabilities, Current $28.39M.
- 2024-06-30: Liabilities, Current $24.52M.
- 2024-03-31: Liabilities, Current $37.30M.
- 2023-12-31: Liabilities, Current $36.68M.
| Period end | Liabilities, Current |
|---|---|
| 2024-09-30 | $28.39M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $24.52M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $37.30M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $36.68M 10-Q · filed 2024-10-31 |
| 2023-09-30 | $28.39M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $28.38M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $23.55M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $30.78M 10-K · filed 2024-03-27 |
| 2022-09-30 | $38.42M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $38.93M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $27.59M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $31.51M 10-K · filed 2023-03-02 |
| 2021-09-30 | $29.88M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $27.62M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $27.37M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $28.62M 10-K · filed 2022-03-15 |
| 2020-09-30 | $28.06M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $23.20M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $19.81M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $23.52M 10-K · filed 2021-03-04 |
| 2019-09-30 | $22.57M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $15.33M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $14.98M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $19.53M 10-K · filed 2020-03-05 |
| 2018-09-30 | $21.30M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $17.68M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $21.34M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $12.41M 10-K · filed 2019-03-07 |
| 2017-09-30 | $9.24M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $7.02M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $6.87M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $9.57M 10-K · filed 2018-03-12 |
| 2016-09-30 | $8.35M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $6.15M 10-Q · filed 2016-08-15 |
| 2015-12-31 | $7.96M 10-K · filed 2017-03-20 |